WAVE3 phosphorylation regulates the interplay between PI3K, TGF-β, and EGF signaling pathways in breast cancer

Wei Wang1, Urna Kansakar1, Vesna Markovic1

  • 1Department of Medicine, Rammelkamp Center for Research, Cleveland, OH, USA.

Oncogenesis
|October 5, 2020
PubMed

Insights

WAVE3 phosphorylation, crucial for breast cancer growth, is regulated by PI3K, TGF-β, and EGF signaling. Inhibiting WAVE3 phosphorylation halts tumor progression and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming Growth Factor-beta (TGF-β) and Phosphatidylinositol 3-kinase-AKT (PI3K-AKT) pathways are key regulators of cell functions, including cancer survival and proliferation.
  • Their interplay is critical in tumor initiation, growth, and progression, particularly in breast cancers.
  • The precise molecular mechanisms linking these pathways and the role of WAVE3 phosphorylation in tumor progression remain incompletely understood.

Purpose of the Study:

  • To investigate the role of WAVE3 phosphorylation in breast cancer development and progression.
  • To elucidate the relationship between WAVE3 phosphorylation and the PI3K-AKT, TGF-β, and Epidermal Growth Factor (EGF) signaling pathways.
  • To determine if WAVE3 phosphorylation is essential for the oncogenic activity of these signaling pathways.

Main Methods:

  • In vitro cell migration, tumorsphere growth, and invasion assays.
  • In vivo studies using mouse models of aggressive triple-negative breast cancer.
  • Analysis of signaling pathway activation and downstream effectors.

Main Results:

  • WAVE3 tyrosine phosphorylation is regulated by PI3K, TGF-β, and EGF signaling and is essential for its oncogenic functions.
  • Loss of WAVE3 phosphorylation significantly inhibited breast cancer cell migration, tumorsphere formation, and invasion in vitro.
  • In vivo, loss of WAVE3 phosphorylation suppressed tumor growth in aggressive breast cancer mouse models.
  • WAVE3 phosphorylation is required for the activation of PI3K, TGF-β, and EGF signaling pathways.

Conclusions:

  • WAVE3 phosphorylation plays a critical role in breast cancer progression and metastasis.
  • A positive feedback loop exists between WAVE3 and the PI3K, TGF-β, and EGF signaling pathways, regulating breast cancer development.
  • Targeting WAVE3 phosphorylation presents a potential therapeutic strategy for breast cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K